Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Erik A. Boss"'
Autor:
Brent C. Opmeer, Katja N. Gaarenstroom, Mirjam J. A. Engelen, M. Caroline Vos, Christiana A. Naaktgeboren, Kees G. Gerestein, Patrick M.M. Bossuyt, Ben W.J. Mol, Anje M. Spijkerboer, Guus Fons, Toon Van Gorp, Petra L.M. Zusterzeel, Henk W.R. Schreuder, Hannah S. van Meurs, Eltjo M.J. Schutter, Roelien van de Vrie, Henk G. ter Brugge, Gemma G. Kenter, Maarten van Haaften, Ward Hofhuis, Erik A. Boss, Marrije R. Buist, Johanna M.A. Pijnenborg, Henriette J. G. Arts, Marianne J. Rutten
Publikováno v:
Journal of Clinical Oncology, 35(6), 613-621. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 35(6), 613. American Society of Clinical Oncology
Journal of clinical oncology, 35(6):6, 613-621. American Society of Clinical Oncology
Journal of Clinical Oncology, 35, 6, pp. 613-621
Journal of Clinical Oncology, 35(6), 613
Journal of Clinical Oncology, 35, 613-621
Journal of Clinical Oncology, 35(6), 613-621. American Society of Clinical Oncology
Journal of Clinical Oncology, 35(6), 613. American Society of Clinical Oncology
Journal of clinical oncology, 35(6):6, 613-621. American Society of Clinical Oncology
Journal of Clinical Oncology, 35, 6, pp. 613-621
Journal of Clinical Oncology, 35(6), 613
Journal of Clinical Oncology, 35, 613-621
Journal of Clinical Oncology, 35(6), 613-621. American Society of Clinical Oncology
Purpose To investigate whether initial diagnostic laparoscopy can prevent futile primary cytoreductive surgery (PCS) by identifying patients with advanced-stage ovarian cancer in whom > 1 cm of residual disease will be left after PCS. Patients and Me
Autor:
Ruud L.M. Bekkers, Saskia Houterman, Jurgen M.J. Piek, Celine S. Bhugwandass, Erik A. Boss, Anna A.M. van der Wurff, Gerritje W.J. van Rijn
Publikováno v:
European Journal of Gynaecological Oncology. 42:286
Autor:
Florine A. Eggink, Roy F. L. P. Kruitwagen, Erik A. Boss, Dennis van Hamont, Huy Ngo, Hans W. Nijman, Tim Wollinga, Constantijne H. Mom, Johanna M.A. Pijnenborg, Nicole P. M. Ezendam, Brenda M. Pijlman, Dorry Boll, Marieke Smink, Maaike A. van der Aa, Elisabeth J.M. Robbe
Publikováno v:
Gynecological Surgery, 15
Gynecological Surgery, 15(1):7. Springer Verlag
Gynecological Surgery, 15:7. Springer
Gynecological Surgery, Vol 15, Iss 1, Pp 1-8 (2018)
Wollinga, T, Ezendam, N P M, Eggink, F A, Smink, M, van Hamont, D, Pijlman, B, Boss, E, Robbe, E J, Ngo, H, Boll, D, Mom, C H, van der Aa, M A, Kruitwagen, R F L P, Nijman, H W & Pijnenborg, J M A 2018, ' Implementation of laparoscopic hysterectomy for endometrial cancer over the past decade ', Gynecological Surgery, vol. 15, no. 1, pp. 7 . https://doi.org/10.1186/s10397-018-1040-x
Gynecological Surgery
Gynecological Surgery, 15(1). Springer Verlag
Gynecological surgery, 15(1):7
Gynecological Surgery, 15:Unsp 7. Springer-Verlag
Gynecological Surgery, 15(1):7. Springer Verlag
Gynecological Surgery, 15:7. Springer
Gynecological Surgery, Vol 15, Iss 1, Pp 1-8 (2018)
Wollinga, T, Ezendam, N P M, Eggink, F A, Smink, M, van Hamont, D, Pijlman, B, Boss, E, Robbe, E J, Ngo, H, Boll, D, Mom, C H, van der Aa, M A, Kruitwagen, R F L P, Nijman, H W & Pijnenborg, J M A 2018, ' Implementation of laparoscopic hysterectomy for endometrial cancer over the past decade ', Gynecological Surgery, vol. 15, no. 1, pp. 7 . https://doi.org/10.1186/s10397-018-1040-x
Gynecological Surgery
Gynecological Surgery, 15(1). Springer Verlag
Gynecological surgery, 15(1):7
Gynecological Surgery, 15:Unsp 7. Springer-Verlag
Background Laparoscopic hysterectomy (LH) for the treatment of early-stage endometrial carcinoma/cancer (EC) has demonstrated to be safe in several randomized controlled trials. Yet, data on implementation of LH in clinical practice are limited. In t
Autor:
Nicole P. M. Ezendam, Helena J.M.M. Mertens, Ralph H. Hermans, Wobbe P. Zijlstra, Joke E. Haartsen, Erik A. Boss, Jan A. Roukema, Johannes J. van Beek, Johanna M.A. Pijnenborg, Dorry Boll, M. Caroline Vos, Kim A.H. Nicolaije, Lonneke V. van de Poll-Franse, Willem E. Nolting, Ingrid E.A.M. van Loon-Baelemans, Brenda M. Pijlman, Karin C.M. Engelhart, Roy F.P.M. Kruitwagen
Publikováno v:
Journal of Clinical Oncology, 33(31), 3550-3559. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 33(31), 3550-+. American Society of Clinical Oncology
Journal of Clinical Oncology, 33(31), 3550-+. American Society of Clinical Oncology
Purpose This study was conducted to longitudinally assess the impact of an automatically generated survivorship care plan (SCP) on patient-reported outcomes in routine clinical practice. Primary outcomes were patient satisfaction with information and
Autor:
Maarten van Haaften, Marrije R. Buist, Marianne J. Rutten, Ward Hofhuis, Katja N. Gaarenstroom, Erik A. Boss, Brent C. Opmeer, Eltjo M.J. Schutter, Mirjam J. A. Engelen, Ben W.J. Mol, Kees G. Gerestein, Hannah S. van Meurs, Henriette J. G. Arts, Henk W.R. Schreuder, Gemma G. Kenter, M. Caroline Vos, Johanna M.A. Pijnenborg, Henk G. ter Brugge, Roelien van de Vrie, Christiana A. Naaktgeboren, Patrick M.M. Bossuyt, Toon Van Gorp, Petra L.M. Zusterzeel
Publikováno v:
van de Vrie, R, van Meurs, H S, Rutten, M J, Naaktgeboren, C A, Opmeer, B C, Gaarenstroom, K N, van Gorp, T, Ter Brugge, H G, Hofhuis, W, Schreuder, H W R, Arts, H J G, Zusterzeel, P L M, Pijnenborg, J M A, van Haaften, M, Engelen, M J A, Boss, E A, Vos, M C, Gerestein, K G, Schutter, E M J, Kenter, G G, Bossuyt, P M M, Mol, B W & Buist, M R 2017, ' Cost-effectiveness of laparoscopy as diagnostic tool before primary cytoreductive surgery in ovarian cancer ', Gynecologic Oncology, vol. 146, no. 3, pp. 449-456 . https://doi.org/10.1016/j.ygyno.2017.06.019
Gynecologic Oncology, 146, 3, pp. 449-456
Gynecologic oncology, 146(3), 449-456. Academic Press Inc.
Gynecologic Oncology, 146, 449-456
Gynecologic Oncology, 146(3), 449-456
Gynecologic Oncology, 146(3), 449-456. ACADEMIC PRESS INC ELSEVIER SCIENCE
Gynecologic Oncology, 146(3), 449. Academic Press Inc.
Gynecologic Oncology, 146(3), 449-456. Elsevier Science
Gynecologic Oncology, 146(3), 449-456. Academic Press Inc.
Gynecologic Oncology, 146, 3, pp. 449-456
Gynecologic oncology, 146(3), 449-456. Academic Press Inc.
Gynecologic Oncology, 146, 449-456
Gynecologic Oncology, 146(3), 449-456
Gynecologic Oncology, 146(3), 449-456. ACADEMIC PRESS INC ELSEVIER SCIENCE
Gynecologic Oncology, 146(3), 449. Academic Press Inc.
Gynecologic Oncology, 146(3), 449-456. Elsevier Science
Gynecologic Oncology, 146(3), 449-456. Academic Press Inc.
Objective. To evaluate the cost-effectiveness of a diagnostic laparoscopy prior to primary cytoreductive surgery to prevent futile primary cytoreductive surgery (i.e. leaving >1 cm residual disease) in patients suspected of advanced stage ovarian 'ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51c10a69c6ee51faf8fa2fa7c5415e8f
https://research.vumc.nl/en/publications/a0f57e98-dd36-45e7-9df4-eeabdb2963bb
https://research.vumc.nl/en/publications/a0f57e98-dd36-45e7-9df4-eeabdb2963bb
Autor:
Ingrid E.A.M. van Loon-Baelemans, Willem E. Nolting, Erik A. Boss, Kim A.H. Nicolaije, Johannes J. van Beek, Nicole P. M. Ezendam, Jan A. Roukema, Ralph H. Hermans, Joke E. Haartsen, Johanna M.A. Pijnenborg, M. Caroline Vos, Roy F.P.M. Kruitwagen, Dorry Boll, Karin C.M. Engelhart, Belle H. de Rooij, Lonneke V. van de Poll-Franse, Helena J.M.M. Mertens, Brenda M. Pijlman
Publikováno v:
Gynecologic Oncology, 145, 319-328
Gynecologic Oncology, 145, 2, pp. 319-328
Gynecologic Oncology, 145(2), 319-328. Elsevier Science
Gynecologic Oncology: An International Journal, 145(2), 319-328. Academic Press Inc.
Gynecologic Oncology, 145, 2, pp. 319-328
Gynecologic Oncology, 145(2), 319-328. Elsevier Science
Gynecologic Oncology: An International Journal, 145(2), 319-328. Academic Press Inc.
Item does not contain fulltext OBJECTIVE: The aim of this study was to assess the long-term impact of an automatically generated Survivorship Care Plan (SCP) on patient reported outcomes in ovarian cancer in routine clinical practice. Outcome measure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e39dd5fef7a5440d97312ab74a26eb11
http://hdl.handle.net/2066/174732
http://hdl.handle.net/2066/174732
Autor:
Willem M. Ankum, Harold R. Verhoeve, Antonius B. Dijkman, L. van der Leeuw-Harmsen, F. van der Veen, M.H. Emanuel, J. P. Lips, Jaap Friederich, M. van Wely, M.A. van Kessel, Neriman Bayram, B.W. Mol, N.M. van Mello, Albert H. Adriaanse, Femke Mol, Erik A. Boss, Petra J. Hajenius
Publikováno v:
van Mello, N M, Mol, F, Verhoeve, H R, van Wely, M, Adriaanse, A H, Boss, E A, Dijkman, A B, Bayram, N, Emanuel, M H, Friederich, J, van der Leeuw-Harmsen, L, Lips, J P, Van Kessel, M A, Ankum, W M, van der Veen, F, Mol, B W & Hajenius, P J 2013, ' Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations? A randomized comparison ', Human Reproduction, vol. 28, no. 1, pp. 60-7 . https://doi.org/10.1093/humrep/des373
Human Reproduction, 28(1), 60-7. Oxford University Press
Human reproduction (Oxford, England), 28(1), 60-67. Oxford University Press
Human Reproduction, 28(1), 60-7. Oxford University Press
Human reproduction (Oxford, England), 28(1), 60-67. Oxford University Press
STUDY QUESTION: What is the treatment success rate of systemic methotrexate (MTX) compared with expectant management in women with an ectopic pregnancy or a pregnancy of unknown location (PUL) with low and plateauing serum hCG concentrations?SUMMARY
Autor:
Revathy B. Iyer, Perry W. Grigsby, Erik A. Boss, Ebrahim S. Delpassand, Bruno D. Fornage, Michele Follen, Elliot K. Fishman, Charles F. Levenback
Publikováno v:
Cancer, 98, 2028-38
Cancer, 98, 9 Suppl, pp. 2028-38
Cancer, 98, 9 Suppl, pp. 2028-38
Item does not contain fulltext Cervical cancer traditionally has been staged clinically. Advances in imaging could improve the staging of cervical cancer by facilitating the detection of lymph node metastases and micrometastases in distant organs. Su
Autor:
C.G.J. Sweep, Anneke Geurts-Moespot, H. Boonstra, Erik A. Boss, Chris M.G. Thomas, Leon F. A. G. Massuger
Publikováno v:
Cancer. 91:371-377
BACKGROUND The purpose of the current study was to determine vascular endothelial growth factor (VEGF) concentrations in cyst fluid from malignant, borderline, and benign ovarian tumors, and to correlate these data with preoperative serum VEGF concen
Autor:
Brenda M. Pijlman, Ralph H. Hermans, Johannes J. van Beek, Lonneke V. van de Poll-Franse, Joke E. Haartsen, Helena J.M.M. Mertens, Olga Husson, Karin C.M. Engelhart, Roy F.P.M. Kruitwagen, Jan A. Roukema, Willem E. Nolting, Kim A.H. Nicolaije, MC Vos, Johanna M.A. Pijnenborg, Dorry Boll, Erik A Boss, Nicole P. M. Ezendam, Harrie W. H. Feijen
Publikováno v:
Trials
Trials, Vol 12, Iss 1, p 256 (2011)
Trials, 12:256. BioMed Central
Trials, Vol 12, Iss 1, p 256 (2011)
Trials, 12:256. BioMed Central
Background There is a need for improvement of information provision and post-treatment care for cancer survivors. A Survivorship Care Plan (SCP) is recommended by the American Institute of Medicine and the Dutch Health Council, which is a summary of